Click2learn Forms Alliance With GeneEd To Provide Complete E-Learning Solutions To Pharmaceutical Industry
Combined 21 CFR 11 Infrastructure and Content Solutions Ensure Timely Delivery of Critical, Up-to-Date Scientific Information in Compliance With Federal Standards
BELLEVUE, Wash.–(BUSINESS WIRE)–June 27, 2002–Click2learn (Nasdaq: CLKS) today announced that it has formed a go-to-market alliance with GeneEd, the leading provider of e-learning content focused on life sciences.
Under the agreement, the two companies will jointly develop and market Web-based learning solutions to the healthcare and pharmaceutical industries that marry the comprehensive technology infrastructure of Click2learn’s Aspen Learning Platform with GeneEd’s unique learning content.
“There is a critical need within pharmaceutical companies to rapidly share new information in order to be able to act upon it quickly,” said Kevin Oakes, Click2learn chairman and CEO. “Our alliance with GeneEd uniquely positions us to serve this highly specialized industry. GeneEd’s top-notch content partnered with the power of Aspen technology will help these companies bring their products to market faster, while still meeting exacting quality and regulatory standards.”
“With its integrated learning management, content management and synchronous learning capabilities, Aspen is the ideal vehicle to deliver and manage GeneEd’s science-centric e-learning knowledge dissemination platform,” said Sunil Maulik, GeneEd chairman and CEO. “Delivering this content to pharmaceutical company employees anytime, anywhere, will help increase their productivity and, in turn, will help these organizations realize significantly increased business performance.”
Aspen complies with strict federal rules regarding electronic records through its 21 CFR 11 compliance module, making it an ideal tool for pharmaceutical companies by enhancing their ability to digitally enter, track and manage updates to training records for more cost-effective administration of its learning programs.
Click2learn (Nasdaq: CLKS) is a provider of enterprise software for Global 2000 organizations seeking to capture, manage and disseminate knowledge throughout their extended enterprise. Using Click2learn’s Aspen Enterprise Learning Platform, organizations can deploy highly interactive, personalized learning initiatives to achieve strategic business objectives. Many of the world’s best-known corporations use Click2learn’s technology to improve workforce performance, educate customers, and publish large volumes of learning content. Click2learn’s clients include Accenture, Albertson’s, American Airlines, AstraZeneca, Century 21, Fujitsu, Microsoft, Pfizer, Symantec, and Towers Perrin. Based in Bellevue, Wash., Click2learn (www.click2learn.com, 800/448-6543) operates offices in the United States and Europe.
GeneEd, Inc. was founded in 1997 to provide life science and healthcare e-learning solutions through the creation of compelling, multimedia-based training, using the Internet and corporate Intranets as the primary delivery platform. GeneEd uses the best life science content, combined with a validated methodology for repurposing, to rapidly create basic and advanced curricula in the areas of genomics, drug discovery and development, pharmacogenetics and clinical genomics, and therapeutic and diagnostic products. GeneEd, Inc. is a privately held company headquartered in San Francisco, California. Visit http://www.GeneEd.com for additional information about GeneEd and its courseware.
This announcement contains forward-looking statements that involve risks and uncertainties, including information contained in this document where statements are preceded by, followed by or include the words “believes,” “plans,” “intends,” “expects,” “anticipates” or similar expressions. For such statements, The Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Factors that could cause actual results to differ from those contained in the forward-looking statements include, market acceptance of Click2learn’s e-learning solutions and competing e-learning offerings, the ability to successfully implement Click2learn’s solutions and increase revenues, the ability to successfully address technological developments and standards and the risk factors set forth in filings the Company has made with the SEC.
Click2learn, Aspen and ToolBook are trademarks of Click2learn. All other company and product names are the trademarks of their respective owners.